A meta-analysis that evaluated the impact of statins alone or combined with metformin in PCOS patients demonstrated a significant decline in total testosterone and free testosterone, DHES, androstenedione, LH, LH/FSH ratio, and prolactin in the statin group. The gene discussed is BRD2; the disease is polycystic ovary syndrome.